168 related articles for article (PubMed ID: 34462295)
21. Multiple myeloma: Role of autologous transplantation.
Ntanasis-Stathopoulos I; Gavriatopoulou M; Kastritis E; Terpos E; Dimopoulos MA
Cancer Treat Rev; 2020 Jan; 82():101929. PubMed ID: 31770695
[TBL] [Abstract][Full Text] [Related]
22. Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy.
Kleber M; Udi J; Metzke B; Terpos E; Roodmann GD; Morgan G; Dispenzieri A; Einsele H; Wäsch R; Engelhardt M
Leuk Lymphoma; 2012 Jun; 53(6):1057-61. PubMed ID: 22149167
[TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma: the present and the future.
Joshua DE
Med J Aust; 2005 Oct; 183(7):344. PubMed ID: 16201949
[TBL] [Abstract][Full Text] [Related]
24. Current treatment options for myeloma.
Terpos E; Rahemtulla A; Dimopoulos MA
Expert Opin Pharmacother; 2005 Jun; 6(7):1127-42. PubMed ID: 15957967
[TBL] [Abstract][Full Text] [Related]
25. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
van Rhee F
Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
[No Abstract] [Full Text] [Related]
26. Managing multiple myeloma in the over 70s: a review.
King AJ; Gooding S; Ramasamy K
Maturitas; 2015 Feb; 80(2):148-54. PubMed ID: 25541475
[TBL] [Abstract][Full Text] [Related]
27. Medical management update: multiple myeloma.
Stoopler ET; Vogl DT; Stadtmauer EA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):599-609. PubMed ID: 17291793
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma.
Oksman MJ; Itälä-Remes M; Kauppila M; Putkonen M; Salmenniemi U; Salmi T; Remes K
Bone Marrow Transplant; 2015 Jan; 50(1):157. PubMed ID: 25310301
[No Abstract] [Full Text] [Related]
29. Atraumatic bone pain in multiple myeloma secondary to bisphosphonate-related bone injury.
Williams R; Wolger L; Alajangi R
Br J Haematol; 2021 Jan; 192(2):229. PubMed ID: 33094837
[No Abstract] [Full Text] [Related]
30. Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review.
Mateos MV; Fink L; Koneswaran N; Intorcia M; Giannopoulou C; Niepel D; Cavo M
BMC Cancer; 2020 Mar; 20(1):170. PubMed ID: 32126974
[TBL] [Abstract][Full Text] [Related]
31. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
[TBL] [Abstract][Full Text] [Related]
32. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
Veltri LW; Milton DR; Delgado R; Shah N; Patel K; Nieto Y; Kebriaei P; Popat UR; Parmar S; Oran B; Ciurea S; Hosing C; Lee HC; Manasanch E; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH; Bashir Q
Cancer; 2017 Sep; 123(18):3568-3575. PubMed ID: 28513828
[TBL] [Abstract][Full Text] [Related]
33. Treatment of newly diagnosed multiple myeloma.
Palumbo A; Magarotto V; Larocca A; Bringhen S; Falco P; Di Raimondo F; Baldini L; Boccadoro M
Curr Hematol Malig Rep; 2008 Apr; 3(2):107-14. PubMed ID: 20425454
[TBL] [Abstract][Full Text] [Related]
34. Biology and treatment of myeloma related bone disease.
Terpos E; Christoulas D; Gavriatopoulou M
Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
[TBL] [Abstract][Full Text] [Related]
35. The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myeloma.
Merz AMA; Merz M; Hillengass J; Holstein SA; McCarthy P
Expert Rev Anticancer Ther; 2019 Oct; 19(10):889-898. PubMed ID: 31595807
[No Abstract] [Full Text] [Related]
36. Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions.
Alegre A
Bone Marrow Transplant; 2009 Apr; 43(8):593-5. PubMed ID: 19384344
[No Abstract] [Full Text] [Related]
37. Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.
Maybury B; Cook G; Pratt G; Yong K; Ramasamy K
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1926-1937. PubMed ID: 27288955
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate therapy in the treatment of multiple myeloma.
Lawson MA; Ashcroft J; Croucher PI
Curr Pharm Des; 2010; 16(27):3028-36. PubMed ID: 20722619
[TBL] [Abstract][Full Text] [Related]
39. Stem Cell Transplantation in Multiple Myeloma.
Offidani M; Gentili S; Gay F; Aghemo E; Maracci L; Corvatta L; Palumbo A
Curr Cancer Drug Targets; 2017; 17(9):769-781. PubMed ID: 27659429
[TBL] [Abstract][Full Text] [Related]
40. How is patient care for multiple myeloma advancing?
Genadieva Stavric S; Bonello F; Bringhen S; Boccadoro M; Larocca A
Expert Rev Hematol; 2017 Jun; 10(6):551-561. PubMed ID: 28504554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
